Immunogen | 营业费用

Operating Expenses 更改 日
AbbVie USD 11.11B 540M 2023-12
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Amgen USD 6.93B 2.11B 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Eli Lilly USD 6.97B 2.08B 2023-12
Exelixis USD 489.5M 97.5M 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06



Immunogen 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.